[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS GAMMA-A AND GAMMA-B).
DOI=10.1021/bi00329a041; PubMed=2990550 [NCBI, ExPASy, EBI, Israel, Japan]
Rixon M.W.,
Chung D.W.,
Davie E.W.;
"Nucleotide sequence of the gene for the gamma chain of human fibrinogen.";
Biochemistry 24:2077-2086(1985).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
DOI=10.1021/bi00282a033; PubMed=6688357 [NCBI, ExPASy, EBI, Israel, Japan]
Chung D.W.,
Chan W.-Y.,
Davie E.W.;
"Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen.";
Biochemistry 22:3250-3256(1983).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-140 AND ARG-191.
SeattleSNPs program for genomic applications;
Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-A).
TISSUE=Fetal liver;
Zhang C.,
Yu Y.,
Zhang S.,
Wei H.,
Zhou G.,
Bi J.,
Zhang Y.,
Liu M.,
He F.;
"Functional prediction of the coding sequences of 33 new genes deduced by analysis of cDNA clones from human fetal liver.";
Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-A).
TISSUE=Skeletal muscle;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
PROTEIN SEQUENCE OF 27-437.
Henschen A.,
Lottspeich F.,
Southan C.,
Topfer-Petersen E.;
"Human fibrinogen: sequence, sulfur bridges, glycosylation and some structural variants.";
(In) Peeters H. (eds.); Protides of the biological fluids, Proc. 28th colloquium, pp.51-56, Pergamon Press, Oxford (1980).
|
[7]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 75-286.
TISSUE=Liver;
PubMed=1685103 [NCBI, ExPASy, EBI, Israel, Japan]
Marchetti L.,
Zanelli T.,
Malcovati M.,
Tenchini M.L.;
"Polymorphism of the human gamma chain fibrinogen gene.";
DNA Seq. 1:419-422(1991).
|
[8]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 285-437 (ISOFORMS GAMMA-A AND GAMMA-B).
PubMed=6092346 [NCBI, ExPASy, EBI, Israel, Japan]
Fornace A.J. Jr.,
Cummings D.E.,
Comeau C.M.,
Kant J.A.,
Crabtree G.R.;
"Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen.";
J. Biol. Chem. 259:12826-12830(1984).
|
[9]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 209-270.
DOI=10.1093/nar/11.21.7427; PubMed=6689067 [NCBI, ExPASy, EBI, Israel, Japan]
Imam A.M.A.,
Eaton M.A.W.,
Williamson R.,
Humphries S.;
"Isolation and characterisation of cDNA clones for the A alpha- and gamma-chains of human fibrinogen.";
Nucleic Acids Res. 11:7427-7434(1983).
|
[10]
|
PROTEIN SEQUENCE OF 411-453 (ISOFORM GAMMA-B).
DOI=10.1021/bi00524a036; PubMed=7306501 [NCBI, ExPASy, EBI, Israel, Japan]
Wolfenstein-Todel C.,
Mosesson M.W.;
"Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma').";
Biochemistry 20:6146-6149(1981).
|
[11]
|
REVIEW, AND DISULFIDE BONDS.
PubMed=6575689 [NCBI, ExPASy, EBI, Israel, Japan]
Henschen A.,
Lottspeich F.,
Kehl M.,
Southan C.;
"Covalent structure of fibrinogen.";
Ann. N. Y. Acad. Sci. 408:28-43(1983).
|
[12]
|
DISULFIDE BONDS.
Doolittle R.F.,
Takagi T.,
Watt K.W.K.,
Bouma H. III,
Cottrell B.A.,
Cassman K.G.,
Goldbaum D.M.,
Doolittle L.R.,
Friezner S.J.;
"The structures of fibrinogen and fibrin.";
(In) Magnusson S., Ottesen M., Foltmann B., Dano K., Neurath H. (eds.); Regulatory proteolytic enzymes and their inhibitors, pp.163-172, Pergamon Press, New York (1978).
|
[13]
|
DISULFIDE BONDS.
DOI=10.1016/0049-3848(76)90245-0; PubMed=936108 [NCBI, ExPASy, EBI, Israel, Japan]
Blombaeck B.,
Hessel B.,
Hogg D.;
"Disulfide bridges in NH2-terminal part of human fibrinogen.";
Thromb. Res. 8:639-658(1976).
|
[14]
|
QUATERNARY STRUCTURE, AND DISULFIDE BONDS.
DOI=10.1021/bi00278a003; PubMed=6860649 [NCBI, ExPASy, EBI, Israel, Japan]
Hoeprich P.D.,
Doolittle R.F.;
"Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation.";
Biochemistry 22:2049-2055(1983).
|
[15]
|
SULFATION.
DOI=10.1021/bi00103a004; PubMed=1892842 [NCBI, ExPASy, EBI, Israel, Japan]
Farrel D.H.,
Mulvihill E.R.,
Huang S.,
Chung D.W.,
Davie E.W.;
"Recombinant human fibrinogen and sulfation of the gamma' chain.";
Biochemistry 30:9414-9420(1991).
|
[16]
|
SULFATION AT TYR-444 AND TYR-448.
PubMed=11307817 [NCBI, ExPASy, EBI, Israel, Japan]
Meh D.A.,
Siebenlist K.R.,
Brennan S.O.,
Holyst T.,
Mosesson M.W.;
"The amino acid sequence in fibrin responsible for high affinity thrombin binding.";
Thromb. Haemost. 85:470-474(2001).
|
[17]
|
REVIEW, ELECTRON MICROSCOPY, POLYMERIZATION, AND LIGANDS.
PubMed=6383194 [NCBI, ExPASy, EBI, Israel, Japan]
Doolittle R.F.;
"Fibrinogen and fibrin.";
Annu. Rev. Biochem. 53:195-229(1984).
|
[18]
|
POLYMERIZATION SITE.
PubMed=6592597 [NCBI, ExPASy, EBI, Israel, Japan]
Horwitz B.H.,
Varadi A.,
Scheraga H.A.;
"Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.";
Proc. Natl. Acad. Sci. U.S.A. 81:5980-5984(1984).
|
[19]
|
POLYMERIZATION SITE.
PubMed=6451630 [NCBI, ExPASy, EBI, Israel, Japan]
Olexa S.A.,
Budzynski A.Z.;
"Localization of a fibrin polymerization site.";
J. Biol. Chem. 256:3544-3549(1981).
|
[20]
|
PLATELET AGGREGATION SITE.
DOI=10.1021/bi00303a028; PubMed=6326808 [NCBI, ExPASy, EBI, Israel, Japan]
Kloczewiak M.,
Timmons S.,
Lukas T.J.,
Hawiger J.;
"Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.";
Biochemistry 23:1767-1774(1984).
|
[21]
|
PLATELET AGGREGATION SITE.
PubMed=6325435 [NCBI, ExPASy, EBI, Israel, Japan]
Plow E.F.,
Srouji A.H.,
Meyer D.,
Marguerie G.,
Ginsberg M.H.;
"Evidence that three adhesive proteins interact with a common recognition site on activated platelets.";
J. Biol. Chem. 259:5388-5391(1984).
|
[22]
|
CALCIUM-BINDING SITE.
PubMed=3160702 [NCBI, ExPASy, EBI, Israel, Japan]
Dang C.V.,
Ebert R.F.,
Bell W.R.;
"Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence.";
J. Biol. Chem. 260:9713-9719(1985).
|
[23]
|
CHROMATOGRAPHIC COMPARISON OF GAMMA-A AND GAMMA-B CHAINS.
PubMed=6933547 [NCBI, ExPASy, EBI, Israel, Japan]
Wolfenstein-Todel C.,
Mosesson M.W.;
"Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').";
Proc. Natl. Acad. Sci. U.S.A. 77:5069-5073(1980).
|
[24]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-78, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1002/pmic.200300556; PubMed=14760718 [NCBI, ExPASy, EBI, Israel, Japan]
Bunkenborg J.,
Pilch B.J.,
Podtelejnikov A.V.,
Wisniewski J.R.;
"Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.";
Proteomics 4:454-465(2004).
|
[25]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-78, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[26]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-78, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1074/mcp.M500324-MCP200; PubMed=16263699 [NCBI, ExPASy, EBI, Israel, Japan]
Lewandrowski U.,
Moebius J.,
Walter U.,
Sickmann A.;
"Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.";
Mol. Cell. Proteomics 5:226-233(2006).
|
[27]
|
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 169-437.
DOI=10.1016/S0969-2126(97)00171-8; PubMed=9016719 [NCBI, ExPASy, EBI, Israel, Japan]
Yee V.C.,
Pratt K.P.,
Cote H.C.F.,
le Trong I.,
Chung D.W.,
Davie E.W.,
Stenkamp R.E.,
Teller D.C.;
"Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.";
Structure 5:125-138(1997).
|
[28]
|
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 169-437.
DOI=10.1073/pnas.94.14.7176; PubMed=9207064 [NCBI, ExPASy, EBI, Israel, Japan]
Pratt K.P.,
Cote H.C.F.,
Chung D.W.,
Stenkamp R.E.,
Davie E.W.;
"The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro.";
Proc. Natl. Acad. Sci. U.S.A. 94:7176-7181(1997).
|
[29]
|
X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 114-432.
DOI=10.1038/38947; PubMed=9333233 [NCBI, ExPASy, EBI, Israel, Japan]
Spraggon G.,
Everse S.J.,
Doolittle R.F.;
"Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.";
Nature 389:455-462(1997).
|
[30]
|
X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 114-432.
DOI=10.1021/bi9804129; PubMed=9628725 [NCBI, ExPASy, EBI, Israel, Japan]
Everse S.J.,
Spraggon G.,
Veerapandian L.,
Riley M.,
Doolittle R.F.;
"Crystal structure of fragment double-D from human fibrin with two different bound ligands.";
Biochemistry 37:8637-8642(1998).
|
[31]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 114-432.
DOI=10.1021/bi982626w; PubMed=10074346 [NCBI, ExPASy, EBI, Israel, Japan]
Everse S.J.,
Spraggon G.,
Veerapandian L.,
Doolittle R.F.;
"Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide.";
Biochemistry 38:2941-2946(1999).
|
[32]
|
VARIANT ASAHI THR-336.
PubMed=2496144 [NCBI, ExPASy, EBI, Israel, Japan]
Yamazumi K.,
Shimura K.,
Terukina S.,
Takahashi N.,
Matsuda M.;
"A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi.";
J. Clin. Invest. 83:1590-1597(1989).
|
[33]
|
VARIANTS ASAHI; KYOTO-1; KYOTO-3 AND OSAKA-2.
PubMed=1421174 [NCBI, ExPASy, EBI, Israel, Japan]
Mimuro J.,
Muramatsu S.,
Maekawa H.,
Sakata Y.,
Kaneko M.,
Yoshitake S.,
Okuma M.,
Ito Y.,
Takeda Y.,
Matsuda M.;
"Gene analyses of abnormal fibrinogens with a mutation in the gamma chain.";
Int. J. Hematol. 56:129-134(1992).
|
[34]
|
VARIANT BALTIMORE-1 VAL-318.
PubMed=2257302 [NCBI, ExPASy, EBI, Israel, Japan]
Bantia S.,
Mane S.M.,
Bell W.R.,
Dang C.V.;
"Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly-->Val (GGC-->GTC) mutation.";
Blood 76:2279-2283(1990).
|
[35]
|
VARIANT BALTIMORE-3 ILE-334.
PubMed=2328317 [NCBI, ExPASy, EBI, Israel, Japan]
Bantia S.,
Bell W.R.,
Dang C.V.;
"Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308-->Ile mutation.";
Blood 75:1659-1663(1990).
|
[36]
|
VARIANT BERN-1 LYS-363.
PubMed=8400260 [NCBI, ExPASy, EBI, Israel, Japan]
Steinmann C.,
Reber P.,
Jungo M.,
Laemmle B.,
Heinemann G.,
Wermuth B.,
Furlan M.;
"Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.";
Blood 82:2104-2108(1993).
|
[37]
|
VARIANT KYOTO-1 LYS-334.
PubMed=2971046 [NCBI, ExPASy, EBI, Israel, Japan]
Yoshida N.,
Terukina S.,
Okuma M.,
Moroi M.,
Aoki N.,
Matsuda M.;
"Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.";
J. Biol. Chem. 263:13848-13856(1988).
|
[38]
|
VARIANT KYOTO-3 TYR-356.
PubMed=2819242 [NCBI, ExPASy, EBI, Israel, Japan]
Terukina S.,
Yamazumi K.,
Okamoto K.,
Yamashita H.,
Ito Y.,
Matsuda M.;
"Fibrinogen Kyoto III: a congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization.";
Blood 74:2681-2687(1989).
|
[39]
|
VARIANT MILANO-1 VAL-356.
PubMed=3708159 [NCBI, ExPASy, EBI, Israel, Japan]
Reber P.,
Furlan M.,
Rupp C.,
Kehl M.,
Henschen A.,
Mannucci P.M.,
Beck E.A.;
"Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp-->Val impairs fibrin polymerization.";
Blood 67:1751-1756(1986).
|
[40]
|
VARIANT MILANO-5 CYS-301.
PubMed=7841300 [NCBI, ExPASy, EBI, Israel, Japan]
Steinmann C.,
Boegli C.,
Jungo M.,
Laemmle B.,
Heinemann G.,
Wermuth B.,
Redaelli R.,
Baudo F.,
Furlan M.;
"Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.";
Blood Coagul. Fibrinolysis 5:463-471(1994).
|
[41]
|
VARIANT MILANO-7 CYS-384.
PubMed=8080993 [NCBI, ExPASy, EBI, Israel, Japan]
Steinmann C.,
Boegli C.,
Jungo M.,
Laemmle B.,
Heinemann G.,
Wermuth B.,
Redaelli R.,
Baudo F.,
Furlan M.;
"A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization.";
Blood 84:1874-1880(1994).
|
[42]
|
VARIANT NAGOYA-1 ARG-355.
PubMed=2738036 [NCBI, ExPASy, EBI, Israel, Japan]
Miyata T.,
Furukawa K.,
Iwanaga S.,
Takamatsu J.,
Saito H.;
"Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the gamma-chain that impairs the polymerization of fibrin monomer.";
J. Biochem. 105:10-14(1989).
|
[43]
|
VARIANT OSAKA-2 CYS-301.
PubMed=2971042 [NCBI, ExPASy, EBI, Israel, Japan]
Terukina S.,
Matsuda M.,
Hirata H.,
Takeda Y.,
Miyata T.,
Takao T.,
Shimonishi Y.;
"Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, 'fibrinogen Osaka II'. Evidence for a unique solitary cystine structure at the mutation site.";
J. Biol. Chem. 263:13579-13587(1988).
|
[44]
|
VARIANT OSAKA-3 HIS-301.
PubMed=1455400 [NCBI, ExPASy, EBI, Israel, Japan]
Yoshida N.,
Imoka S.,
Hirata H.,
Matsuda M.,
Asakura S.;
"Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.";
Thromb. Haemost. 68:534-538(1992).
|
[45]
|
VARIANT OSAKA-5 GLY-401.
PubMed=1733971 [NCBI, ExPASy, EBI, Israel, Japan]
Yoshida N.,
Hirata H.,
Morigami Y.,
Imaoka S.,
Matsuda M.,
Yamazumi K.,
Asakura S.;
"Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis.";
J. Biol. Chem. 267:2753-2759(1992).
|
[46]
|
VARIANT PARIS-1.
PubMed=8470043 [NCBI, ExPASy, EBI, Israel, Japan]
Rosenberg J.B.,
Newman P.J.,
Mosesson M.W.,
Guillin M.-C.,
Amrani D.L.;
"Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.";
Thromb. Haemost. 69:217-220(1993).
|
[47]
|
VARIANT TOCHIGI CYS-301.
PubMed=3337908 [NCBI, ExPASy, EBI, Israel, Japan]
Yoshida N.,
Ota K.,
Moroi M.,
Matsuda M.;
"An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine.";
Blood 71:480-487(1988).
|
[48]
|
VARIANT VLISSINGEN 345-ASN-ASP-346 DEL.
PubMed=2071611 [NCBI, ExPASy, EBI, Israel, Japan]
Koopman J.,
Haverkate F.,
Briet E.,
Lord S.T.;
"A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.";
J. Biol. Chem. 266:13456-13461(1991).
|
[49]
|
VARIANT BERGAMO-2/ESSEN/HAIFA/PERUGIA HIS-301.
PubMed=3563970 [NCBI, ExPASy, EBI, Israel, Japan]
Reber P.,
Furlan M.,
Henschen A.,
Kaudewitz H.,
Barbui T.,
Hilgard P.,
Nenci G.G.,
Berrettini M.,
Beck E.A.;
"Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg-->His): fibrinogens Bergamo II, Essen and Perugia.";
Thromb. Haemost. 56:401-406(1986).
|
[50]
|
VARIANT SAGA HIS-301.
PubMed=2976995 [NCBI, ExPASy, EBI, Israel, Japan]
Yamazumi K.,
Terukina S.,
Onohara S.,
Matsuda M.;
"Normal plasmic cleavage of the gamma-chain variant of 'fibrinogen Saga' with an Arg-275 to His substitution.";
Thromb. Haemost. 60:476-480(1988).
|
[51]
|
VARIANT MILANO-12 ARG-191.
DOI=10.1182/blood.V98.2.351; PubMed=11435303 [NCBI, ExPASy, EBI, Israel, Japan]
Bolliger-Stucki B.,
Lord S.T.,
Furlan M.;
"Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, A-alpha R16C and gamma G165R.";
Blood 98:351-357(2001).
|
[52]
|
VARIANTS ARG-191 AND VAL-410.
DOI=10.1038/10290; PubMed=10391209 [NCBI, ExPASy, EBI, Israel, Japan]
Cargill M.,
Altshuler D.,
Ireland J.,
Sklar P.,
Ardlie K.,
Patil N.,
Shaw N.,
Lane C.R.,
Lim E.P.,
Kalyanaraman N.,
Nemesh J.,
Ziaugra L.,
Friedland L.,
Rolfe A.,
Warrington J.,
Lipshutz R.,
Daley G.Q.,
Lander E.S.;
"Characterization of single-nucleotide polymorphisms in coding regions of human genes.";
Nat. Genet. 22:231-238(1999).
|
[53]
|
ERRATUM.
Cargill M.,
Altshuler D.,
Ireland J.,
Sklar P.,
Ardlie K.,
Patil N.,
Shaw N.,
Lane C.R.,
Lim E.P.,
Kalyanaraman N.,
Nemesh J.,
Ziaugra L.,
Friedland L.,
Rolfe A.,
Warrington J.,
Lipshutz R.,
Daley G.Q.,
Lander E.S.;
Nat. Genet. 23:373-373(1999).
|
[54]
|
VARIANT HILLSBOROUGH ASP-335.
DOI=10.1182/blood.V99.10.3597; PubMed=11986213 [NCBI, ExPASy, EBI, Israel, Japan]
Mullin J.L.,
Brennan S.O.,
Ganly P.S.,
George P.M.;
"Fibrinogen Hillsborough: a novel gamma-gly309asp dysfibrinogen with impaired clotting.";
Blood 99:3597-3601(2002).
|
|
ExPASy Home page
